Should combination treatments be the standard of care to maximise efficacy for myopia treatment?
Saved in:
| Title: | Should combination treatments be the standard of care to maximise efficacy for myopia treatment? |
|---|---|
| Authors: | Sankaridurg, Padmaja (AUTHOR), Chia, Audrey (AUTHOR), Kang, Pauline (AUTHOR) |
| Source: | Ophthalmic & Physiological Optics. Jun2025, Vol. 45 Issue 4, p918-922. 5p. |
| Subjects: | Myopia, Combination drug therapy, Treatment effectiveness, Medical protocols, Research questions, Therapeutics |
| Abstract: | The article discusses the debate on whether combination treatments should be the standard of care for myopia management. While some argue that combining different treatment modalities may provide synergistic effects, others believe that the evidence supporting combination therapy is weak and the benefits are modest. Factors such as efficacy, compliance, financial burden, and management complexities need to be carefully considered when deciding between monotherapy and combination treatments. The article highlights the need for further research to determine the best approach for maximizing efficacy in myopia treatment. [Extracted from the article] |
| Copyright of Ophthalmic & Physiological Optics is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
|
Full text is not displayed to guests.
Login for full access.
|
|
| Abstract: | The article discusses the debate on whether combination treatments should be the standard of care for myopia management. While some argue that combining different treatment modalities may provide synergistic effects, others believe that the evidence supporting combination therapy is weak and the benefits are modest. Factors such as efficacy, compliance, financial burden, and management complexities need to be carefully considered when deciding between monotherapy and combination treatments. The article highlights the need for further research to determine the best approach for maximizing efficacy in myopia treatment. [Extracted from the article] |
|---|---|
| ISSN: | 02755408 |
| DOI: | 10.1111/opo.13474 |
